MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with O

Orforglipron

Orforglipron 2.5mg tablets

No stability information

Stability notes for Orforglipron 2.5mg tablets

There are no stability notes for this medicine.

Supplier

Foundayo 2.5mg tablets (Eli Lilly and Company Ltd)

Orforglipron 5.5mg tablets

No stability information

Stability notes for Orforglipron 5.5mg tablets

There are no stability notes for this medicine.

Supplier

Foundayo 5.5mg tablets (Eli Lilly and Company Ltd)

Orforglipron 9mg tablets

No stability information

Stability notes for Orforglipron 9mg tablets

There are no stability notes for this medicine.

Supplier

Foundayo 9mg tablets (Eli Lilly and Company Ltd)

Orforglipron 14.5mg tablets

No stability information

Stability notes for Orforglipron 14.5mg tablets

There are no stability notes for this medicine.

Supplier

Foundayo 14.5mg tablets (Eli Lilly and Company Ltd)

Orforglipron 17.2mg tablets

No stability information

Stability notes for Orforglipron 17.2mg tablets

There are no stability notes for this medicine.

Supplier

Foundayo 17.2mg tablets (Eli Lilly and Company Ltd)

Orforglipron 800microgram tablets

No stability information

Stability notes for Orforglipron 800microgram tablets

There are no stability notes for this medicine.

Supplier

Foundayo 0.8mg tablets (Eli Lilly and Company Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.